Sign in
4

Changes in Ownership

ADC Therapeutics SA Filed Acc 0001628280-26-009278

Chief Financial Officer acquired 271,600 shares (grant or award)

  • Chief Financial Officer gave up 25,880 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Carmona Jose Chief Financial Officer 2026-02-13 Grant or award +271,600 $3.99 $1,083,684 760,256 D
Carmona Jose Chief Financial Officer 2026-02-13 Shares withheld for taxes −25,880 $3.99 $103,261 734,376 D
Loading xslF345X05/wk-form4_1771454570.xml…